Related Experiment Videos
Incentivizing behaviour change to improve diabetes care.
N M Petry1, E Cengiz, J A Wagner
1Calhoun Cardiology Center and Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
Diabetes, Obesity & Metabolism
|April 12, 2013
Summary
Behavioural economics uses incentives to encourage healthy behaviors in healthcare. Reinforcement interventions show success in diabetes prevention and management, improving adherence and monitoring.
Area of Science:
- Behavioral Economics
- Health Psychology
- Health Behavior Interventions
Background:
- Behavioral economics studies psychological and cognitive factors influencing decision-making.
- This field is increasingly applied in healthcare, utilizing incentives for healthy lifestyle behaviors.
Purpose of the Study:
- To review the background and efficacy of reinforcement interventions in general.
- To examine the application of these interventions in diabetes prevention and management.
Main Methods:
- Review of existing literature on reinforcement interventions.
- Analysis of applications in diabetes-related behaviors such as appointment attendance, weight loss, exercise, medication adherence, and blood glucose monitoring.
Main Results:
- Reinforcement interventions have demonstrated notable success in promoting healthy behaviors.
- Specific successes include improved medical appointment attendance, weight loss, exercise, medication adherence, and blood glucose monitoring in diabetes care.
Conclusions:
- Reinforcement interventions are effective tools for behavior change in healthcare settings.
- Further research into promising areas is suggested, acknowledging the controversial nature of these interventions.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...